Comparison of clinical effect between temozomide and nimustine in patients with malignant gliomas

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 13, 2007, Pages 1021-1022

  Ji, Yu Ming ^a   Xin, Ling ^a   Yang, Guo Kuan ^b  

^a Laiyang Central Hospital   (China)

^b Yantai Mountain Hospital   (China)

Author keywords

Comparative study; Drug therapy; Glioma

Indexed keywords

NIMUSTINE; TEMOZOLOMIDE;

ADULT; ARTICLE; BODY SURFACE; BRAIN TOMOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST RADIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 77953406140     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chinese source.
2. Chinese source.
3. Dannies J, Cave, Huang S, et al. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrrent malignant glioma[J]. Br J Cancer, 2002, 86(4): 501-505.
4. Stupp R, Dietrich P Y, Ostermann K, et al. Promising survival for patient with newly diagnosed glioblastorna multiform treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide[J]. J Clin Oncol, 2002, 20(5): 1375-1382.
5. Randes A A, Ermani M, Basso U, et al. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study[J]. Ann Onclo, 2001,12(2): 255-257.
6. Pruitt A A, Rosenfeld M R. 10 questions about temozolomide and the treatment of brain tumors[J]. Neurologist, 2005, 11 (6): 362-365.
7. Corsa P, Parisi S, Raguso A, et al. Temozolimide and radiotherapy as first-line treatment of high-grade gliomas[J]. Tumori, 2006, 92(4): 299-305.
8. Papuashvili G S, Gagua R O, Ninua N G. Temozolomide - a new antitumor preparation in the treatment of central nervous system malignant tumors[J]. Georgian Med News, 2006, (134): 31-34.